KRISTEN RINALDI: Open Payments
NPI 1558543546 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 70 payments from 21 companies in 2025. Trend: 2023 $1,316 · 2024 $1,621 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $413 |
| TOLMAR, INC. | 7 | $179 |
| UROGEN PHARMA, INC. | 4 | $126 |
| Astellas Pharma US Inc | 5 | $124 |
| Merck Sharp & Dohme LLC | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $104 |
| Antares Pharma, Inc. | 4 | $102 |
| Endo USA, Inc. | 3 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $65 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $64 |
Products named: GEMTESA, JATENZO, ORGOVYX, Xtandi, KEYTRUDA, Nubeqa, XYOSTED, JOURNAVX.
Industry payments across CT — which companies pay providers there.
